Tech Company Financing Transactions
EpiVario Funding Round
EpiVario, based in Philadelphia, secured $445 thousand from private investors.
Transaction Overview
Company Name
Announced On
12/13/2018
Transaction Type
Venture Equity
Amount
$445,000
Round
Seed
Investors
Proceeds Purpose
The funds will be used to hire additional research staff and support the first phase of preclinical research milestones.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3401 Grays Ferry Ave.
Philadelphia, PA 19146
USA
Philadelphia, PA 19146
USA
Phone
Website
Email Address
Not Recorded
Overview
EpiVario is rooted in its expertise in epigenetics. Using that rich source of learning, we are revolutionizing therapies for psychiatric disorders that plague a significant portion of the population, including those suffering from post-traumatic stress disorder, alcohol and drug addiction, Alzheimer's disease, and dementia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Kim
Co-Founder
Shelley Berger
Co-Founder
Philipp Mews
Browse more venture capital transactions:
Prev: 12/13/2018: Happiest Baby venture capital transaction
Next: 12/13/2018: MediBeacon venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs